Annals of Diagnostic Pathology
Volume 11, Issue 1 , Pages 34-38 , February 2007

Intraductal growth–type mucin-producing peripheral cholangiocarcinoma associated with biliary papillomatosis

  • Mine G. Güllüoglu, MD

      Affiliations

    • Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, 34390 Istanbul, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 212 414 23 98; fax: +90 212 631 13 67.
    • ,
  • Ilgin Ozden, MD

      Affiliations

    • Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, 34390 Istanbul, Turkey
    • ,
  • Arzu Poyanli, MD

      Affiliations

    • Department of Radiology, Istanbul Faculty of Medicine, Istanbul University, 34390 Istanbul, Turkey
    • ,
  • Ugur Cevikbas, MD

      Affiliations

    • Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, 34390 Istanbul, Turkey
    • ,
  • Orhan Ariogul, MD

      Affiliations

    • Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, 34390 Istanbul, Turkey

References 

  1. Lee SS, Kim M, Lee SK, et al. Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer. 2004;100:783–793
  2. Yeung YP, Ahchong K, Chung CK, et al. Biliary papillomatosis: report of seven cases and review of English literature. J Hepatobiliary Pancreat Surg. 2003;10:390–395
  3. Holtkamp W, Reis HE. Papillomatosis of the bile ducts: papilloma-carcinoma sequence. Am J Gastroenterol. 1994;89:2253–2255
  4. Taguchi J, Yasunaga M, Kojiro M, et al. Intrahepatic and extrahepatic biliary papillomatosis. Arch Pathol Lab Med. 1993;117:944–947
  5. Nakanuma Y, Sasaki M, Ishikawa A, et al. Biliary papillary neoplasm of the liver. Histol Histopathol. 2002;17:851–861
  6. Albores-Saavedra J, Scoazec JC, Wittekind C, et al. Carcinoma of the bladder and extrahepatic bile ducts. In:  Hamilton SR,  Aaltonen LA editor. WHO classification of tumours, pathology and genetics, tumours of the digestive system. Lyon: IARC Press; 2000;p. 206–214
  7. Callea F, Sergi C, Fabretti G, et al. Precancerous lesions of the biliary tree. J Surg Oncol Suppl. 1993;3:131–133
  8. Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51(Suppl 6):VI1–VI9
  9. Chen MF, Jan YY, Chen TC. Clinical studies of mucin producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases. Ann Surg. 1998;227:63–69
  10. Yonezawa S, Sueyoshi K, Nomoto M, et al. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. Hum Pathol. 1997;28:344–352
  11. Shimonishi T, Zen Y, Chen TC, et al. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Hum Pathol. 2002;33:503–511
  12. Yeh CN, Jan YU, Yeh TS, Hwang TL, Chen MF. Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol. 2004;11:606–611
  13. Suh KS, Roh HR, Koh YT, et al. Clinicapathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology. 2000;31:12–17
  14. Higashi M, Yonezawa S, Ho JJL, et al. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology. 1999;30:1347–1355
  15. Yeh TS, Tseng JH, Chen TC, et al. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth type and its precursor lesions. Hepatology. 2005;42:657–664
  16. Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001;34:651–658
  17. Shibahara H, Tamada S, Goto M, et al. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:327–338
  18. Nakanuma Y, Harada K, Ishikawa A, et al. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobiliary Pacreat Surg. 2003;10:265–281
  19. Kim HJ, Kim MH, Lee SK, et al. Mucin hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy. 2000;32:389–393
  20. Abraham SC, Lee JH, Hruban RH, et al. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol. 2003;34:902–910
  21. Ohta T, Nagakawa T, Ueda N, et al. Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis. Cancer. 1991;68:2217–2223
  22. Lau CM, Yuen ST, Yuen WK, Fan ST. Biliary papillomatosis. Br J Surg. 1996;83:1715–1716
  23. Ohita H, Yamaguchi Y, Yamakawa O, et al. Biliary papillomatosis with the point mutation of K-ras gene arising in congenital choledochal cyst. Gastroenterology. 1993;105:1209–1212
  24. Lee PSF, Au Yeung KM, Chan YI. Biliary papillomatosis complicating recurrent pyogenic cholangitis. Clin Radiol. 2001;56:591–593
  25. Wolf HK, Garcia JA, Bossen EH. Oncocytic differentiation in intrahepatic biliary cystadenocarcinoma. Mod Pathol. 1992;5:665–668
  26. Sudo Y, Harada K, Tsuneyama K, et al. Oncocytic biliary cystadenocarcinoma is a form of intraductal oncocytic papillary neoplasm of the liver. Mod Pathol. 2001;14:1304–1309
  27. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol. 1993;143:1050–1054
  28. Ramos-Vara JA, Miller MA. Immunohistochemical characterization of canine intestinal epithelial and masenchymal tumours with a monoclonal antibody to hepatocyte paraffin 1 (Hep Par 1). Histochem J. 2002;34:397–401
  29. Villari D, Caruso R, Grosso M, et al. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study. Pathology. 2002;34:423–426
  30. Chu PG, Jiang Z, Weiss LW. Hepatocyte antigen as a marker of intestinal metaplasia. Am J Surg Pathol. 2003;27:952–959
  31. Kawakatsu M, Vilgrain V, Zins M, et al. Radiologic features of papillary adenoma and papillomatosis of the biliary tract. Abdom Imaging. 1997;22:87–90
  32. Ma KF, Iu PP, Chau LF, et al. Clinical and radiological features of biliary papillomatosis. Australas Radiol. 2000;44:169–173

PII: S1092-9134(06)00127-4

doi: 10.1016/j.anndiagpath.2006.09.003

Annals of Diagnostic Pathology
Volume 11, Issue 1 , Pages 34-38 , February 2007

Article Tools

* Image Usage & Resolution